Jenkins Annalisa bought MREO
February 26, 2026 · Form 4 insider transaction
Jenkins Annalisa bought 106,848 shares of Mereo BioPharma Group plc, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
106,848
Price
N/A
Total value
N/A
InsiderJenkins Annalisa
Role—
SecurityDeferred Restricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after106,848
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.; Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.